A detailed history of Armstrong, Fleming & Moore, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Armstrong, Fleming & Moore, Inc holds 7,962 shares of MRK stock, worth $1 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
7,962
Previous 7,961 0.01%
Holding current value
$1 Million
Previous $868 Million 21.04%
% of portfolio
0.73%
Previous 0.65%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$113.24 - $131.95 $113 - $131
1 Added 0.01%
7,962 $1.05 Billion
Q4 2023

Feb 05, 2024

SELL
$100.18 - $109.02 $9,717 - $10,574
-97 Reduced 1.2%
7,961 $868 Million
Q3 2023

Nov 02, 2023

SELL
$102.95 - $114.33 $39,635 - $44,017
-385 Reduced 4.56%
8,058 $830 Million
Q2 2023

Aug 16, 2023

BUY
$108.61 - $118.38 $916,994 - $999,482
8,443 New
8,443 $974 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Armstrong, Fleming & Moore, Inc Portfolio

Follow Armstrong, Fleming & Moore, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong, Fleming & Moore, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong, Fleming & Moore, Inc with notifications on news.